Results 231 to 240 of about 549,379 (280)

Induction Camrelizumab and Modified TPF (Nab‐Paclitaxel, Cisplatin, and S‐1) in Locoregionally Advanced Nasopharyngeal Carcinoma

Cancer Science, Volume 116, Issue 6, Page 1616-1626, June 2025.
ABSTRACT Induction chemo‐immunotherapy has emerged as a potential treatment option for locoregionally advanced nasopharyngeal carcinoma (LANPC). This study aimed to evaluate the efficacy and safety of camrelizumab combined with modified TPF (nab‐paclitaxel, cisplatin, and S‐1) as induction chemo‐immunotherapy in LANPC.
Yi‐Feng Yu, Ya‐Qing Dai, Zong‐Kai Zhang, Guan‐Zhong Lu, Qin Lin, San‐Gang Wu   +5 more
wiley   +1 more source

Concurrent chemoradiotherapy with alternate-day administration of S-1 for locally advanced squamous cell carcinoma of the head and neck -Preliminary results

, 2010
Sakae Taira
openalex   +2 more sources

Women's Experience and Management of Cancer‐Related Fatigue and Psychological Distress During Treatment for Gynaecological Cancer: A Qualitative Study

Journal of Advanced Nursing, Volume 81, Issue 6, Page 3213-3225, June 2025.
ABSTRACT Aim To explore women's experience and management of cancer‐related fatigue and psychological distress during treatment for gynaecological cancer. Design Qualitative descriptive study. Methods Face‐to‐face semistructured individual interviews were conducted with 23 women in mainland China undergoing treatment for gynaecological cancer between ...
Xing Ma, Qian Wang, Dorothy Ngo Sheung Chan   +2 more
wiley   +1 more source

Therapeutic options for human papillomavirus‐positive tonsil and base of tongue cancer

Journal of Internal Medicine, Volume 297, Issue 6, Page 608-629, June 2025.
Abstract The incidences of human papillomavirus‐positive (HPV+) tonsillar and base tongue squamous cell carcinomas (TSCC and BOTSCC) have increased in recent decades. Notably, HPV+ TSCC and BOTSCC have a significantly better prognosis than their HPV‐negative counterparts when treated with current surgical options, radiotherapy, or intensified ...
Mark Zupancic, Ourania N. Kostopoulou, Linda Marklund, Tina Dalianis   +3 more
wiley   +1 more source

Association Between Preoperative Frailty Using Frailty Index‐Laboratory Test and Clinical Outcomes in Older Adults Undergoing Brain Tumor Surgery

Nursing &Health Sciences, Volume 27, Issue 2, June 2025.
ABSTRACT This retrospective cohort study aimed to evaluate preoperative frailty in older adults undergoing brain tumor surgery using the laboratory‐based frailty index (FI‐LAB) and its association with clinical outcomes. Data were from electronic medical records of individuals aged ≥ 65 years who had brain tumor surgery between 2015 and 2022 at a ...
Sang Ok Kim, Youn‐Jung Son, JiYeon Choi   +2 more
wiley   +1 more source

Patients survey after concurrent chemoradiotherapy

, 2010
Toshikazu Shimane, Syunya Egawa, Tomoaki Mori, Tomohiro Ono, Tetsuya Monden, Sei Kobayashi, Takeyuki Sanbe, Harumi Suzaki   +7 more
openalex   +2 more sources

Symptom Experience After Surgical Treatment for Vulvar Cancer—A Scoping Review

Scandinavian Journal of Caring Sciences, Volume 39, Issue 2, June 2025.
ABSTRACT Background Previous reviews have indicated a high burden of physical, emotional and sexual symptoms in women who have undergone surgery for vulvar cancer. Numerous surgical modifications have been made over the past few decades to limit post‐operative symptoms.
Anne Marie Thimm, Eva Helena Hansson, Katrine Bak Wraae, Mette Linnet Olesen   +3 more
wiley   +1 more source

A case of marked response to preoperative concurrent chemoradiotherapy with an optimum dose of TS-1 for upper gingival carcinoma that invaded to the pterygopalatine fossa in a chronic renal failure patient maintained on hemodialysis, enabling curative resection

, 2010
Kou Kawahara, Yuji Kamiya, Toshiharu Yamada, Hiroyuki Watanabe, Daisuke Sano, Kou Ishii, Nobuyoshi Ozawa, Noriko Tanaka   +7 more
openalex   +2 more sources

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

CA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 203-215, May/June 2025.
Abstract Background Nearly 90% locoregionally advanced nasopharyngeal carcinoma (LANPC) responds to induction chemotherapy (IC) with significant tumor volume shrinkage. Radiotherapy always follows IC, and reduced volume has been proposed. However, the efficacy and safety of reduced‐volume radiotherapy is uncertain.
Ling‐Long Tang, Lin Chen, Gui‐Qiong Xu, Ning Zhang, Cheng‐Long Huang, Wen‐Fei Li, Yan‐Ping Mao, Guan‐Qun Zhou, Feng Lei, Lu‐Si Chen, Shao Hui Huang, Lei Chen, Yu‐Pei Chen, Yuan Zhang, Xu Liu, Cheng Xu, Yin Zhao, Ji‐Bin Li, Na Liu, Fang‐Yun Xie, Rui Guo, Ying Sun, Jun Ma   +22 more
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source